HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM— 510(k) K820192
Substantially EquivalentHyland Therapeutic Div., Travenol Laboratories
FDA 510(k) clearance K820192 for HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM, Substantially Equivalent on 1982-03-11. Applicant: Hyland Therapeutic Div., Travenol Laboratories.
Clearance details
- Applicant
- Hyland Therapeutic Div., Travenol Laboratories
- Product code
- Code GRP
- Advisory panel
- Microbiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Walker, MI, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.